for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Huadong Medicine Co., Ltd.

000963.SZ

Latest Trade

25.07CNY

Change

0.03(+0.12%)

Volume

4,599,820

Today's Range

24.90

 - 

25.26

52 Week Range

19.30

 - 

32.55

As of on the Shenzhen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
25.04
Open
25.03
Volume
4,599,820
3M AVG Volume
358.00
Today's High
25.26
Today's Low
24.90
52 Week High
32.55
52 Week Low
19.30
Shares Out (MIL)
1,749.81
Market Cap (MIL)
43,815.23
Forward P/E
15.54
Dividend (Yield %)
1.10

Latest Developments

More

Huadong Medicine's Net Profit Up In Jan-Sept, Q3

Huadong Medicine Scraps Plan To Buy Stake In Zhejiang Jolly Pharmaceutical

Huadong Medicine's H1 Net Profit Up 23.42% Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Huadong Medicine Co., Ltd.

HUADONG MEDICINE CO . , LTD is a China-based company principally engaged in the production and distribution of chemical drugs, traditional Chinese medicines and preparations. The Company’s main products consist of immunosuppressive preparations, diabetes drugs, drugs for digestive system diseases, and drugs for kidney diseases, among others. The Company is also involved in medical instrument and health products businesses. The Company distributes its products in domestic market and to overseas markets.

Industry

Major Drugs

Contact Info

No. 866, Moganshan Road

+86.571.89903300

http://www.eastchinapharm.com/

Executive Leadership

Bangliang Li

Chairman of the Board

Honglan Ma

Finance Director

Liang Lu

General Manager, Director

Yuedong Li

Deputy General Manager, Director

Shunhua Zhou

Deputy General Manager

Key Stats

1.47 mean rating - 17 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2016

25.4K

2017

27.8K

2018

30.7K

2019(E)

34.9K
EPS (CNY)

2016

0.833

2017

1.017

2018

1.292

2019(E)

1.612
Price To Earnings (TTM)
16.40
Price To Sales (TTM)
1.25
Price To Book (MRQ)
3.76
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
22.95
LT Debt To Equity (MRQ)
1.53
Return on Investment (TTM)
24.48
Return on Equity (TTM)
13.73

Latest News

Latest News

BRIEF-Huadong Medicine's Q3, 9-month net profits up more than 20 pct y/y

* Says 9-month net profit up 24.6 percent y/y at 1.5 billion yuan ($226.24 million), Q3 net profit up 20.3 percent y/y

BRIEF-Huadong Medicine's H1 net profit up 26.5 pct y/y

* Says H1 net profit up 26.5 percent y/y at 1.0 billion yuan ($151.68 million)

BRIEF-Huadong Medicine unit to buy two new drug technologies for totaling 130 mln yuan

* Says its unit plans to buy two new drug technologies for totaling 130 mln yuan

BRIEF-Huadong Medicine to pay FY 2016 annual div on May 24

Huadong Medicine Co Ltd : * Says it plans to pay FY 2016 annual div on May 24 Source text in Chinese: https://goo.gl/L3rZs5 Further company coverage: (Beijing Headline News)

BRIEF-Huadong Medicine's Q1 net profit up 25.1 pct y/y

* Says Q1 net profit up 25.1 percent y/y at 544.0 million yuan ($79.01 million)

BRIEF-Huadong Medicine announces FY 2016 dividend payment

* Says it plans to use undistributed profits to pay a cash dividend of 13.5 yuan (pre-tax) per 10 shares to shareholders for FY 2016

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up